Enzolytics Inc (ENZC)

[foxi]

Outstanding post, thanks!

Some positive and exciting possibilities. It'd be awesome if it could play out that way.

I'd note that Gaurav Chandra, Charles Cotropia, Joseph Cotropia, Suraj Saggar, and Kirsten Bischof would all have new roles under SAGA, according to this PR. I'd be surprised if they're able to split time with ENZC. How would that benefit SAGA? What IP would be left to work with? Today's PR suggests ENZC would still try to find a use for RobustoMed.

A point I'd like to see clarified is that ENZC says "There is no dividend, or preemption rights with common equity" in its OTC filings, but they tease issuing dividend shares in the PRs. Today's PR does use the phrasing "intention to declare a dividend and subject to and upon approval by the regulatory entities". Only Preferred C and D are currently listed as actually having dividend rights. It seems like ENZC would need to amend its class definition for common, unless 'no dividend rights' still permits issuing a dividend to common shareholders in a business combination scenario, or in goodwill. Maybe somebody with more experience can weigh in. And this is not necessarily a problem, just a technicality to note.